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Abstract: This article describes the development of a reaction database with the objective to collect
data for multiphase reactions involved in small molecule pharmaceutical processes with a search
engine to retrieve necessary data in investigations of reaction-separation schemes, such as the role
of organic solvents in reaction performance improvement. The focus of this reaction database is to
provide a data rich environment with process information available to assist during the early stage
synthesis of pharmaceutical products. The database is structured in terms of reaction classification of
reaction types; compounds participating in the reaction; use of organic solvents and their function;
information for single step and multistep reactions; target products; reaction conditions and reaction
data. Information for reactor scale-up together with information for the separation and other
relevant information for each reaction and reference are also available in the database. Additionally,
the retrieved information obtained from the database can be evaluated in terms of sustainability using
well-known “green” metrics published in the scientific literature. The application of the database is
illustrated through the synthesis of ibuprofen, for which data on different reaction pathways have
been retrieved from the database and compared using “green” chemistry metrics.
Keywords: reaction database; pharmaceutical process engineering; organic solvents; “green”
metrics analysis
1. Introduction
Organic chemistry has an important role to play in the development of synthetic routes for new
drugs during early stage process development. To pursue synthesis at a high level, access to chemical
information is needed, which can be provided by using knowledge databases, experience, literature
review and/or computer-aided tools [1,2]. The retrieved data is used for similarity search, reaction data
retrieval, synthesis route planning, drug discovery-development and prediction of physicochemical
properties [3]. The development of methods, algorithms and tools to systematize data collection,
retrieval of chemical information-data, and to assist the solution approach to many problems related to
the synthesis of molecules in organic chemistry has been developed since the 1970s. The methods and
tools for reaction synthesis are based on retrieving chemical information organized in chemical reaction
databases where data for individual reactions and structural information for different components
involved in the reaction are stored.
Computer-aided tools have been developed to solve problems related to “synthesis” and
“retrosynthesis.” The focus of these tools is to generate a number of possible chemical synthesis
paths for possible precursors (synthesis tree) to achieve the synthesis of a given target compound.
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In retrosynthesis, the process of generating the possible pathways starts from the given target
compound and, by going backwards, the reactions necessary to synthesize the target compound
are identified. In addition, the reactions to produce the reactants of identified reactions are generated.
The process is repeated until commercially available reactants are identified. These approaches are
based on heuristics and logical rules and all of them rely on knowledge databases [4–8]. Recently,
computer-aided tools that are based on algorithmic approaches have been developed, such as The Route
Designer [9], which automatically extracts rules that capture the essence of the reactions in the chemical
reaction database [10]. The tool ICSYNTH utilizes a graph-based approach with available data from
the literature to generate the reaction rules [9]. Many other computer-aided methods and tools for
reaction synthesis have already been developed with different characteristics. For example, tools to
perform combinatorial searches, to screen generated alternatives based on information retrieved from
knowledge databases and to perform extensive reaction assessment calculations [11–15].
Searching for reactions and retrieving the relevant information is a complex problem because it
involves searching for chemical structures (complete or partial), transformation information (reaction
centers), description of the reactions (reaction type, general comments) and numerical data such as
experimental reaction data (including conversion, yield, selectivity, reaction conditions etc.). Reaction
databases that help to organize, store and retrieve data continue to be developed (Houben-Weyl [16]
and Theillheimer [17]), but more recently, the field of reaction databases has evolved further and
databases (see Table 1) such as CASREACT [18], ChemReact [17] and REAXYS (previously Beilstein
plus Reactions) [19] have been established, while reaction databases such as ChemInform [20] have
become well-known.
1.1. General Databases
In these types of database, the information included is focused on organic reactions and synthetic
methods in general. The CASREACT reaction database [18] was started in 1840 and since then
more than 74.9 million reactions have been added as it is updated daily. The information is related
to organic synthesis including organometallics, total synthesis of natural products and biocatalytic
(biotransformation) reactions. This database can be used to provide information on different ways to
produce the same product (single step or multi-step reactions), used for applications of a particular
catalyst and various ways to carry out specific functional group transformations. The REAXYS reaction
database [19]—based on data from Elsevier’s industry-leading chemistry databases (CrossFire Beilstein,
CrossFire Gmelin and Patent Chemistry Database)—includes data for more than 40.7 million reactions,
dating from 1771 to the present. It includes a large number of compounds (organic, inorganic and
organometallic) and experimental reaction details (yield, solvents etc.). It is searchable for reactions,
substances, formulas, and data such as physico-chemical properties data, spectra. Additionally,
the REAXYS database can be used for synthesis route planning. The Current Chemical Reaction (CCR)
database [21] includes over one million organic reactions together with reaction diagrams, critical
conditions and bibliographic data. The Reference library of synthetic methodology (RefLib) covers
reaction data from 1946 to 1992. The database contains information from different sources and the
latest version has a comprehensive heterocyclic chemistry database [17].
The ChemReact reaction database [17] is a closed database that covers the period from 1974 to
1998 and includes over 3.5 million reactions. It is searchable by reaction type and provides information
for the reaction transformation classified by type of reaction and relevant data (bibliographic, spectra
and yield). Chemogenesis is a web-book [22], dealing with chemical reactions and chemical reactivity.
It examines the rich science between the periodic table and the established disciplines of inorganic
and organic chemistry. The Organic Synthesis database [23], includes more than 6000 organic
reactions and is searchable by the reaction type or the structure of the compounds and it provides
information for single and multi-step organic reaction together with reaction components, conditions
and description. The reaction database-Chemical Synthesis [24] enables the user to find reactions
related to reagents or target products and it also provides information with the necessary details of the
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reagents. The Synthetic Pages reaction database [25], covers 292 reactions and provides information for
the optimized reaction procedure. It is searchable by reaction type and/or the structure of the reagent
or the target product. The Chemical Thesaurus reaction database [26] contains 4000 reactions classified
as organic, inorganic, organometallic, transition metal and biochemical.
The WebReaction reaction database [27] covers over 400,000 reactions; it can be searched by defining
the structure of the reactant and the product and it performs search based on the reaction similarity
with focus on reaction center. The Science of Synthesis database (previously Houben-Weyl) [16]
covers information for organic and organometallic reactions with detailed experimental procedures,
methodology evaluation and discussion of the field. Finally, the SPRESI reaction database [28] contains
4.6 million reactions and it enables searching of structures, references and reactions.
The Synthetic Reaction Updated (previously Methods in Organic Synthesis) lists many organic
reactions (in graphical form) and is searchable by reaction type [29].
1.2. Specialized Databases
These databases are specialized in one class of reaction type. The ChemInform reaction
database [20] includes more than 2 million reactions, including organic, enzymatic and microbial
reactions. The available data can be used for the application of new reagents and also for catalysts as
with the preparation of natural and pharmaceutical products. Other aspects that are covered by the
ChemInform database include synthetic procedures, enantio-and diasteroselective syntheses and new
protection/de-protection procedures. The Biotage Pathfinder reaction database [30] is specialized in
the verified methods of microwave synthesis.
The e-EROS (Encyclopedia of Reagents for Organic Synthesis) [31] focuses on the reagents
and catalysts used in organic chemistry for synthesis. The FlowReact Search [32] covers a range
of over 2000 flow chemistry reactions adapted from publications on pharmaceutical, fine chemical
and biotech companies. The Protecting Groups reaction database [33] provides information for
protection, de-protection and trans-protection methods, stability, liability, and reaction conditions,
and includes up-to-date information. Recently, a reaction library focused on generic reactions
(88 reactions, ~20,000 reactants) with high reliability and reasonable yield has been developed by
Masek et al. [34]. The objective of this library is to provide information on synthetically feasible design
ideas for de novo drug design.
Representing chemical reactions in a structured way is a complex task. The reaction information
contained in a database needs to fulfil several criteria and needs to be categorized with respect to their
searchable reaction information. The criteria that a reaction database should fulfill are [17]:
(i) Each reaction is an individual record in the database (detailed and graphical). The reaction
must be able to be retrieved from the database as a detailed record (reagents, products, stoichiometry
etc.). It can also be extracted as a graphical representation where the reaction scheme is shown.
In many databases, the reaction is represented in a graphical form.
(ii) Structural information for target product as well as substrates.
(iii) Reaction centers. The reaction center of a reaction is the collection of atoms and bonds that are
changed during the reaction [3].
(iv) Reaction components must be searchable. Information for the components involved in the
reaction such as reagent, catalysts, solvents etc.
(v) Multistep reactions. In the case of multistep reactions, all reactions (individual and whole
pathway) must be searchable.
(vi) Reaction conditions. Conditions such as pH, temperature, pressure etc. should be searchable by
exact and a suitable range of values.
(vii) Reaction classification. The type of reaction (i.e., esterification) should be searchable.
(viii) Post-processing of the database contents. Export of the retrieved reaction data in other tools
(i.e., MS Excel).
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Many reaction databases have been developed over time—some of them have a large number of
reactions available and others a smaller number, and some of the databases cover the whole range of
the organic and/or inorganic reactions. There are also reaction databases that cover more specialized
reactions such as solid reactions, flow reactions etc. It can also be seen that most of the databases cover
the most important criteria as defined by Zass [17], such as the need for individual reaction records
(criterion i, in Table 1). In Table 1, existing reaction databases are listed and have been classified based
on the different presented criteria. The numbers of reactions, as well as online sources, have also
been listed.
Table 1. Database review. All the databases have been summarized with respect to the number of
reactions and the focus of the database.
Database Number of Reaction Criteria [17] Reference
CASREACT >74.9 million (1840–present) i, iv, v, vi [18]
REAXYS (previously CrossFire Beilstein) 40.7 million (1771–present) i, ii, iv, vii [19]
Theilheimer >72200 (1946–1980) i, v, vi, vii [35]
ChemInform RX >2 million(since 1990–present) i, iv, vi [20]
Current chemical reactions 1,083,758 (1840–present) i, vi [21]
Methods in organic synthesis 33,000 (1999–2014) i, vii [29]
Reference library of synthetic methodology 209.800 (1946–2001) i [17]
ChemReact 3.5 million reactions(1974–1998) i, vii [17]
Chemogenesis - ii, iii [22]
Organic synthesis >6000 (1921–present) i, ii, v, vi, vii [23]
Reaction Database-Chemical Synthesis - i, ii [24]
Synthetic Pages 292 i, ii, vi, vii [25]
The chemical thesaurus 4000 i, ii [26]
WebReactions >400,000 i, ii, iii [27]
Biotage Pathfinder (reaction assisted with microwave technology) >1000 i, vi, vii, viii [30]
e-EROS Encyclopedia of Reagents for Organic Synthesis >70,000 (4000 *) i, ii [31]
FlowReact Search >2000 i (reaction in flow) [32]
Protecting groups - i [33]
Science of Synthesis (previously Houben-Weyl) 240,000 (early 1800s–present) i, ii, iii [16]
SPRESI 4.6 million i, ii, iii [28]
The main objective of this article is to assist pharmaceutical process development in the early
stages of the synthesis route selection and development, by providing enhanced process understanding.
To achieve this task, a data-rich environment where knowledge can be collected, stored and retrieved
is a requirement. A database that covers reactions taking place in pharmaceutical processes covering
information connected to the criteria listed by Zass [17] and additionally covering process information
has been developed to create an environment where process knowledge is available. The connection
of individual reactions to criteria like scalability, cost, expected yield, and reaction steps, ease of
separation, safety and to parameters such as reaction conditions, experimental data and models,
they can improve the process understanding and the decision making process during the synthesis
route selection process. In addition to constraints of high product quality and process economics,
a pharmaceutical process needs to fulfill the criteria for environmental issues. In particular, for
pharmaceutical processes, the environmental sustainability evaluation must be performed during the
early stage of process development [36] before the approval of the regulatory bodies as the re-approval
of the process can be a very expensive process [37]. Constable et al. [38] has reviewed “green” metrics
proposed in literature and these metrics are used to increase the awareness of generated waste sources
from the reaction and to identify opportunities for further improvement. The reviewed “green” metrics
are listed in Table 2, where for each metric an explanation and the equation to quantify the specific
metric are given.
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Table 2. List of metrics that have been proposed for “green” chemistry (reviewed by Constable et al. [38]).
Metric Explanation Equation
Effective Mass yield (EM) The percentage of the mass of product over the overall mass of non-benigncompounds used during the synthesis. EM(%) =
Mass o f products (kg)
Mass o f non−benign reagents (kg) × 100%
E-factor The mass of total waste produced for a given amount of produced product. E− f actor = Total waste (kg)kg product
Atom Economy How much of the reactants remain in the product.
Atom Economy(%) = MW P∑(MW A, B, D, F, G, I) × 100
Where A, B, D, F, G, I: reactants; P: product
Mass Intensity (MI) Total mass used to produce the product. MI = Total mass used in a process or process step (kg)Mass o f product (kg)
Carbon efficiency Percentage of carbon of the reactants that remain in the final product. Carbon e f f iciency (%) = amount o f carbon in productTotal carbon present in reactants × 100
Reaction mass efficiency (RME) Mass of reactants remaining in the product. RME (%) = mass o f product(kg)mass o f reactants (kg) × 10
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This information, in combination with other knowledge databases and computer-aided synthesis
design (CASD) tools developed earlier, provides an opportunity for an integrated approach to the
solution of problems related to synthesis route selection and improvement, taking into account
important process considerations such as the development time to establish the synthesis route,
product quality, cost of manufacture that are often linked to “green” chemistry metrics and the final
approval of regulatory agencies [1]. This process related information is not available in the reaction
databases listed in Table 1, but is needed for plant-wide design, process-operation simulation and
optimization in studies related to sustainability and the economics of processes producing active
pharmaceutical ingredients [39–41].
In this article, the developed reaction database is presented with a specific focus on reactions
(including multiple reactions) taking place in pharmaceutical processes within the pharmaceutical
industry and connecting them with process information. The reactions in this database have been
categorized according to the reaction type, the target product to be produced (when single-step or
multistep reactions are considered), the reaction product and the effect of the solvent use on the
reacting system. Reaction conditions (temperature, pressure etc.), reaction components (reagents,
catalysts etc.), reaction data (conversion, selectivity, etc.), scaling information and finally batch or
continuous processing is included in the developed database. For each reaction entry, a description
of the process exists and the references are provided. A more detailed description of the database
development and structure follows later in this article.
This reaction type database, more specifically, aims to:
1. Identify reactions that are used to produce different types of products (Active Pharmaceutical
Ingredients (API), Intermediates).
2. Identify reactions to be utilized, for a given compound availability.
3. Investigate the function of different type of solvents in single/multiphase reactive systems.
4. Facilitate the choice of the reaction conditions.
5. Evaluate the reaction pathway in terms of yield, cost and sustainability metrics.
6. Facilitate the reactor design from available experimental data and kinetic models.
In addition, with the process information that is included in the database and has been mentioned
in points 1–6 above, the database fulfills most of the criteria defined by Zass [17] (see Table 3). Table 3
provides a comparison of the available database with respect to the criteria given by Zass [17]. It can
be noted that most of the available databases provide information for individual reactions (criterion i)
and molecular structure information on reactants and products (criterion ii). However, the remaining
criteria are covered only in some databases (see Table 3).
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Table 3. List of available databases and the criteria [17] they fulfill. Criterion: (i) individual records of reactions, (ii) chemical structure information, (iii) reaction
centers, (iv) searchable reaction components, (v) multistep reactions, (vi) reaction conditions, (vii) reaction classification, (viii) post-processing information.
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2. Reaction Database
The data required to populate a reaction database to satisfy the abovementioned objectives
has been acquired from numerous published articles and patents. The collected knowledge from
these sources has been structured in the database according to a developed ontology (knowledge
representation) and stored for easy data retrieval and re-use in different likely applications.
The database consists of classes, sub-classes, instances and objects. A class is a representation for
a conceptual grouping of similar terms. Classes are the focus of most ontology. A class describes
concepts in the domain. A class can have subclasses that represent concepts that are more specific
than a super class [42]. A simplified flow-diagram, which serves as a guide for the reaction database
in terms of knowledge representation system, classes and instances of data and information on the
available data, and where information can be found in the article, is shown in Figure 1.
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Figure 1. Simplified flow-diagram highlighting the contents of the reaction database. Figures 2 and 3
provide details of the knowledge representation system, Table 4 provides information on the classification
of the data and Tables 5–10 provide information on the available data.
2.1. Knowledge Representation
For the development of the reaction database, classes have been used to represent the main
knowledge categories such as the reaction type, the reaction, phases involved, how the phases are
created, solvent use, solvent function, type of solvent, reaction conditions, available data and finally
operation mode (listed in Table 4 and shown in Figure 2). The first knowledge class consists of
different reaction types that are commonly found in pharmaceutical processes (i.e., hydrogenation).
The set of these reaction types are called the instances of the class. The second class in the knowledge
representation system (or data) is the reaction, which is divided in four sub-classes; the reactants,
reaction products, and target product and reaction information (see Figure 3). The instances of the
three first sub-classes of the second class are classified in terms of name of the compound, type of the
compound and molecular structure while the fourth class summarizes information for the specific
reaction. This type of information is important to identify the structural changes of the compounds
during the reaction. The fourth class of data consists of instances describing the phases involved in
the specific reaction. It is important to note that this class connects the reaction information with
the reaction performance class, which will be described later, and it has an important role in the
database since in this way, the advantages of using a multiphase or a single-phase system can be
identified. The next two classes of the database consist of instances describing the solvent function,
in case an organic solvent has been used in the reactive system, for example, the solvent function is
“creates a second phase and removes the reaction product,” and the type and name of the used organic
solvent. The last three classes of the data consist of instances describing the reaction performance
under certain conditions. The reaction conditions class consists of instances, which have to do with the
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reaction variables such as reaction temperature, stoichiometric amount, catalyst (type and amount),
pH, pressure and the need to use acid or base. The data class consists of four sub-classes, reaction
data, dynamic data, kinetic model, and scale. The instances of the reaction data sub-classes are
information related to reaction time (or residence time), conversion, selectivity, reaction yield and
overall process yield (usually after isolation and purification). The instances of the dynamic data are
sets of experimental data that can be used to fit or to develop a kinetic model. The next sub-class
describes the availability of kinetic models that can be used either directly, or after fitting to the
experimental data for reaction optimization studies. The last sub-class of the data is a super class that
provides important information on the scale the reaction has been performed. Finally, the last class of
the data is the operation mode, instances of this class can be different operational modes such as batch
reaction or flow reaction.
2.2. Database Structure
Table 4 lists the classes of the data in the first column, the second column relates the classes to the
instances that an individual class contains and in the third column, the instances are listed for different
classes. The structure of the database is visually shown in Figure 2.
Table 4. Main classes of the reaction type database and the instances.
Main Classes Relation with Instances Instances
Reaction Type, T T = [T1, T2, ..., Ti, . . . , Tn]
Ti: reaction type in the knowledge base
(i.e., acylation etc.)
Reaction, R R = [R1, R2, ..., Ri, . . . , Rn]
Ri: reaction of the ith reaction type; for each
reaction information about the reactants and
reaction products are provided as well as
information for the target product and process
(for example: 1st step for production of an API)
Phases involved, P P = [P1, P2, ..., Pi, . . . , Pn]
Pi: phase of the ith reaction
(i.e., organic-aqueous, organic-gas etc.)
How phases are created, C C = [C1, C2, ..., Ci, . . . , Cn] Ci: (i.e., solvent etc.)
Solvent function, F F = [F1, F2, ..., Fi, . . . , Fn] Fi: (i.e., phase creation, carrier etc.)
Solvent type, ST ST = [ST1, ST2, ..., STi, . . . , STn] STi: (i.e., ether, alcohol etc.)
Solvent, S S = [S1, S2, ..., Si, . . . , Sn] Si: Solvents in ith reaction
Reaction condition, RC RC = [RC1, RC2, ..., RCi, . . . , RCn] RCi (i.e., Temperature, composition, cat, pH etc.)
Data, D D = [D1, D2, ..., Di, . . . , Dn]
Di (reaction data: conversion, selectivity, reaction
time, and dynamic data: concentration vs. time,
scale information and kinetic models etc.)
Operation Mode, OP OP = [OP1, OP2, ..., OPi, . . . , OPn] OPi: batch, continuous, fed batch
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In Figure 3, the subclasses and the values of each instance in the “Reaction” class are illustrated.
For example, each reaction has reactants—as well as reaction products—and can be used to eventually
produce a target product (in case of multi-step reactions), each of the sub-classes take values such as
the name of the compound (N), the type of the compound (T, for example, alcohol) and the molecular
structure of the compound. The reaction info subclasses takes text values that can be used to give
useful insights for the reaction.
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3. Statistics of the Reaction Database 
To determine the range of applications and the capability of the reaction database, the statistics 
of the stored data within the database are needed. The statistics are given in terms of number of 
reactions, reaction types, list of APIs, reactions where the use of solvent improves the reaction 
performance and available kinetic models.  
3.1. General Numbers 
In this section, the general statistics of this database are given, for example, total number of 
reactions, total number of APIs, the number of the intermediates, reactions that require solvent, 
multiphase reactions, experimental data, type of reaction operation (batch or continuous, technology 
i.e., microwave technology). The general characteristics of the reaction type database are listed in 
Table 5. 
Table 5. Summary of the information included in the database. 
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ltiphase reactions, experimental data, type of reaction operation (batch or continuous, technology i.e.,
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Table 5. Summary of the information included in the database.
Category Number
Total number of reactions 285
Types of reactions 44
Number of multiphase reactions 88
Number of reaction with solvents 226
Solvent Dissolve, Phase creation, Substrate/catalyst carrier,compound extraction
Number of APIs (with total synthesis pathway) 21
Number of building blocks (type of compounds) 19
Number of experimental data 275 (conversion, selectivity, reaction yield, conditions),32 (dynamic data), 11 (kinetic models)
Number of production mode data 96 (in flow), 203 (in b tch)
Number of application examples 14 (chemicals), 16 (Fine chemicals),251 (pharmaceutic ls)
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3.2. Reaction Types
The different reaction types included in the database are listed in Table 6, together with the number
of the reactions, the catalyst need, the phases (usually) involved and the solvent function if it used.
Table 6. Reaction types included in database, phases involved and function of the used solvent.
Reaction Type Catalyst Phases Solvent Function
1. Alkylation Yes Liquid (org.) Dissolves reactants
Liquid (org.)—Liquid (aq.) Creates second phase
2. Hydrogenation Yes Liquid (org.)—Gas Dissolves reactants
3. Epoxidation Liquid (org.)—Liquid (aq.) Creates second phaseReactant/catalyst carrier
4. Carbonylation Yes
Liquid (org.)—Liquid
(aq)—Gas
Creates phase
Carrier for catalyst
Yes Liquid (org.)—Gas Dissolves reactants
5. Hydroformulation ? Creates second phaseCatalyst carrier
6. Enzymatic reduction Yes Liquid (org.)—Liquid (aq.) Reactant carrierCreates second phase
7. Arylation Yes Liquid (org.)—Liquid (aq.) Creates second phase
Yes Liquid (org.) Dissolves reactants
8. Oxidation Yes Liquid (org.)—Gas Dissolves reactants
9. Transamination yes Liquid (org,)—Liquid (aq.) Creates second phaseProduct removal
10. Saponification No Liquid (org.) Dissolves reactants
11. Amidation Yes/No Liquid (org.)—liquid (aq.) Creates second phaseremoves product
12. Amination Yes Liquid (org.) Dissolves reactants
13. Esterification Yes
Liquid (org.) Solvent free
Liquid (org.) Dissolves reactant
14. Hydrolysis Yes Liquid (org.)—liquid (aq.)
Creates second phase
removes product
Dissolves reactants
15. Aminolysis yes Liquid (org.) Dissolves reactants
16 .Condensation No Liquid (org.) Dissolves reactant
17. Deprotection No Liquid (org.) Dissolves reactant
18. Protection Yes Liquid (org.) Dissolves reactant
19. Dehydration Yes Liquid (org.)—liquid (aq.)
Catalyst carrier
Create second phase
Product removal
20. Cyclization No Liquid (org.)—liquid (aq.) Dissolves reactantProduct separation
21. Lithiation No Liquid (org.) Dissolves reactants
Note: aq.: aqueous and org.: organic.
3.3. Active Pharmaceutical Ingredients (APIs)
In Table 7, the list of the available APIs (or the final drug) in the database is given. The database
includes at least one pathway for each API listed in Table 7. In some cases, more than two completely
different published reaction pathways (for example, for Ibuprofen) exist, which are also listed in the
database. Finally, in some cases efforts have been focused on improving a certain reaction within the
reaction path that has also been included in the knowledge database.
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Table 7. List of APIs and final drugs (*) in the database, of which complete reaction pathway and the
reactions are provided in the database.
APIs
1. 6-aminopenicillanic acid 12. Tramadol
2. Zuchopenthixol 13. Artemisinin
3. 6-Hydroxybuspirone 14. Saxagliptin
4. aliskiren hemifumarate 15. Atazanavir
5. Ibuprofen 16. PDE5 inhibitor *
6. Meclinertant * 17. Axitinib
7. Rufinamide 18. Olanzapine *
8. Ciprofloxacin 19. Amitriptyline
9. Naproxen 20. Tamoxifen
10. OZ439 * (antimalarial drug candidate) 21. Vildagliptin
11. Efavirenz *
3.4. Reaction with Improved Reaction Performance When Solvent Is Used
Reaction improvements in terms of reaction time, reaction volume, yield, conversion and/or
selectivity and post-processing improvement in the separation and purification steps related to solvent
use are considered in database development. The functions of solvent and the possible process
improvements are listed below and summarized in Table 8:
a. Reaction medium.
b. Separation of the main product in order to shift the equilibrium reaction towards the product
side in order to increase the yield and/or reduce the separation steps required.
c. Separation of an inhibitory product to increase the productivity of the reaction.
d. Controlled released of substrate, it might improve the process safety in case of hazardous
compounds or increase selectivity towards the desired product.
e. Reaction volume reduction.
f. Dissolves reactants to increase the reaction rate and/or to avoid process complications when the
reaction involves compounds in solid phase at the reaction conditions.
Table 8. Solvent functions in reaction and their possible improvements.
Possible Improvements
Productivity Process safety Separation steps Waste reduction
So
lv
en
tF
un
ct
io
ns Reaction medium 4 4 - -
Product removal
(phase creation) 4 - 4 4
Substrate carrier
(phase creation) 4 4 - 4
Catalyst carrier
(Phase creation) 4 4 4 4
In Table 9 below, different reactive systems where solvent has been added in order to improve the
reaction performance are listed. Table 9 has been classified based on the reaction type and the main
product—it also gives the reaction phases, the solvent function and the reaction improvement.
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Table 9. List of reactions where the use of the solvent has a specific function that leads in direct reaction performance improvement.
Reaction Type Main Product Phases Solvent Function Improvement
Amidation [1] PDE5 inhibitor Liquid(org.)—Solid Product separation(Product not soluble in solvent) Direct product separation
Enzymatic reduction [43] Chiral alcohols
Liquid (aq.)—Ionic liquid Substrate carrier Increased productivity (82–92% yield)
Liquid (aq.) - Productivity (42–46% yield)
Liquid (aq.)—Organic solvent Substrate carrier Productivity (0% yield)
Alkylation [44] Alyl azides
liquid (org. DMSO) Dissolves reactants High productivity (94% yield) but high waste generation
Liquid (aq.)—liquid (org.
DMSO) Dissolves reactants
High in productivity (94% yield) and lower
waste generation
Liquid (aq.)—liquid (org.
Isopropyl acetate) Dissolves reactants
High productivity (96.5% yield) and lower
waste generation
Liquid (aq.)—liquid (org.
Isooctane) Dissolves reactants
High productivity (91.4% yield) and lower
waste generation
Arylation [45] 3,3-disubstituted oxindoles Liquid (aq.)—liquid (org. THFor Toluene) Dissolve reactants
Increased reaction rate that leads to complete conversion
and high yields compared to single phase systems
Arylation [46] Arylation of Alkynes Liquid (aq)—liquid (org.) Catalysts dissolved in aq. Phase Catalyst recovery while maintaining high yields
Hydrolysis [47] Naproxen Liquid (aq.)—liquid (org.;Hexane or isooctane or toluene)
Product removal
(in organic phase) Increased yield, enzyme stability increases
Hydrolysis [48] 6-amino penicillanic acid Liquid (aq.)—liquid (org.;butyl acetate)
Product removal in the
organic phase
Productivity increases (product removal shifts the
equilibrium reaction towards the product)
Transamination [49] L-2 Aminobutyric acid
Liquid (aq.)—liquid (org.) By-product inhibits the enzyme,removal in the organic phase Increased conversion (96%)
Liquid (aq.) - Conversion (~40%)
Transamination [50] Chiral amines Liquid (aq.)—Resin Product removal Equilibrium shifts towards product side
Enzymatic Reduction [51,52] S-4-Chloro-3-hydroxybutyricacid ethyl ester Liquid (aq.)—liquid (org.) Substrate controlled release Increased reaction productivity
Carbonylation [53,54] Ibuprofen
Gas—Liquid (org.)—Liquid
(aq.) Dissolves catalyst (aq.)
Less waste generated, same productivity, slightly lower
reaction rates, reduction in the separation steps
Gas—Liquid (org.);
MEK-Liquid (aq.)
Dissolves catalyst (aq.);
Dissolves reactants (org.) Increased reaction rates
Transamination [55,56] Sitagliptin Liquid (aq.); DMSO used asco-solvent DMSO dissolves amine donor
Increased productivity; enantiomeric selectivity and less
waste generated
Note: aq.: aqueous and org.: organic.
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3.5. Kinetic Models Available
Table 10 lists the kinetic model availability (found through literature search) and their inclusion
in the reaction database kinetic model library. Some of the available kinetic models in the literature
have been analyzed, validated against experimental data and, if found acceptable, then been used for
reaction optimization in order to establish the design space. In other cases a model has been used by
taking it directly from the reported reference, for example, the model reported by Thakar et al. [57] for
the second hydrogenation step of ibuprofen synthesis has been successfully used without any modification
(of the kinetic parameters) to fit the dynamic experimental data published by Cho et al. [58].
Table 10. Kinetic models availability; * indicates those that are included in the kinetic model library.
Kinetic Models Number Reference
Dehydration 1 [59]
Enzymatic reduction 3 [51,60]
Esterification 1 [61]
Transamination 3* [50,62,63]
Hydrolysis 2 [64,65]
Carbonylation 2* [66–68]
Hydrogenation 2* [57,69]
4. Reaction Database Application
The reaction database has multiple features that can assist in the creation of a data-rich
environment in the early stage pharmaceutical process-product development. The knowledge stored
in the database is searchable by forward or backward search options. As is illustrated in Figure 2, data
can be retrieved for the specific search and the retrieved data is used for reaction improvement studies
in subsequent calculation-analysis.
4.1. Reaction Data
Process improvements are usually related to resources such as development cost and time.
The process of establishing the reactions, the experimental procedure, and the reaction conditions might
require significant resources during the initial reaction screening that is required to identify the reaction
pathway that leads to the production of the desired type of products (i.e., chiral alcohols). However,
having an information-based system that can provide information for reaction identifications, reaction
conditions and experimental procedures, can rapidly reduce the required time and cost of the initial
screening process. The data-rich environment can also provide solution for reaction improvements
related to the mass and heat transfer improvements by the use of new technologies such as flow
reactions using for example new microwave technologies.
The use of experimental data (dynamic or end-points) can assist the improvement of the reaction
system as the effect of reaction variable changes can be understood and quantified. Moreover,
experimental data can be used to develop or to fit kinetic models that capture the behavior of the system
under different conditions. These kinetic models can be used for validation studies, optimization
studies to identify improved reaction conditions, evaluate different operation scenario and/or different
reactor designs and networks.
4.2. Organic Solvents
Another class of process improvement is related to the solvent role during the synthesis step.
There are cases where solvent use might enhance the reaction performance. Solvents might have
different roles such as creating a second phase to remove an inhibitory product and shift the reaction
equilibrium towards the product side, or simply it can create the second phase to remove the product
in order to facilitate the following separation procedure. The solvent can also be used as a carrier
for the controlled release of the substrate in the reaction mixture, which can minimize the amount
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of by-products produced when the concentration of substrate is high. The solvent can also have a
role as the medium of the reaction and broaden the reaction conditions in order to improve reaction
performance or satisfy other process concerns such as process safety. For example, if a reaction takes
place at very low temperatures (<−25 ◦C), the solvent should be liquid at this condition and have the
ability to dissolve the reactants, products and catalyst [70].
4.3. Search Options
The search options of the database in terms of both the retrieved data and the use of that data for
a defined process are given below.
1. Search for reaction types
Different reaction types can be searched in the reaction database, the retrieved results provide
information for the reaction (reactants, product and target product), the solvent role and how
it improves the reaction, reaction conditions (i.e., temperature range, acid/base, different
catalyst) and quantitative data (i.e., conversion, concentration vs. time), and finally applicability
information such as scale or batch/continuous mode. The results can be used as similarity
check, to identify reaction conditions, solvents and possibilities for improvement (i.e., equipment,
production mode, technology) for quick reaction optimization.
2. Search for main products (such as APIs or intermediates or type of products like chiral alcohols)
Searching for main products or type of products, reactions that are used to synthesize this type of
compound can be retrieved. The results are used to identify different ways for synthesis and to
evaluate them in terms of reaction performance, cost, scalability and sustainability.
3. Search for reactants
The results obtained by searching reactants are used to identify ways for further utilizing them in
case they have used or produced a product during a reaction.
4. Multiphase reactions
Multiphase and single reactions where the solvent use has improved the reaction performance
can be searched, the retrieved results are used to identify the role of the multiphase system, for
example, solvent creates a second phase to remove inhibitory by-product and to quantify the
improvement in reaction performance, for example, increased conversion.
To summarize, the information retrieved from the reaction database can be used to:
a. Identify reaction pathways, reaction types, reactants, catalysts, solvents and base/acid.
b. Optimization reaction conditions.
c. Investigate the solvent role in process improvement.
d. Optimize the process development identified reactions in terms of cost, yield and time.
e. Improve the overall process performance in terms of separation process, overall yield,
sustainability, safety, scalability, controllability and utilized mass.
f. Improve reactor design and evaluate different reactor designs.
g. Establish operation procedure for the reactors.
h. Assist in plant-wide design, simulation, and techno-economic optimization.
i. Enhance process understanding.
5. Application Example: Ibuprofen Synthesis and Evaluation
5.1. Problem Definition
To illustrate the applicability of the database, the synthesis of ibuprofen is selected as an example.
The objectives of this example are:
Processes 2017, 5, 58 17 of 25
1. To retrieve data relevant to the reaction pathway of Ibuprofen.
2. Collect data related to individual reactions.
3. Evaluate the alternatives based on green metrics.
Database Search: “Main Product = ‘Ibuprofen’”.
5.1.1. Database Results
The main product sub-class is found in the “Reaction” class and from there information before
(reactants, reaction types) and information forward (solvents, reaction conditions, data etc.) are retrieved.
The database information as retrieved from the database is shown in Figure 4, which contains three
screenshots for the purpose of illustration. Screenshot-1 connects the main product (ibuprofen) to
the reaction type data; screenshot-2 connects the main product to the specific reaction information
(temperature, pressure, solvent use, etc.); screenshot-3 connects the main product to modelling details
(for example, kinetic model). The information is also given in the text as follows:
a. Summary of the findings (reaction pathways, reaction types, operation mode, available data
and reference).
b. For each reaction pathway, each reaction is analyzed in terms of:
i. Reactant, products, by-products, acids/base, solvents, catalysts.
ii. Then the reaction conditions for each reaction is presented.
iii. Finally, the reaction data is presented.
The retrieved information is used for the evaluation of different pathways to produce ibuprofen
using the green chemistry metrics.
The database search gives three different reaction pathways. Pathway 1 consists of three reactive
steps. It has been proposed by Elango et al. [71] and consists of three batch reaction steps—a Friedel
craft acylation, a hydrogenation and finally, a carbonylation step. The first reactive step has been
improved by Lindley et al. [72] using a continuous counter flow reaction-separation system which
enables the recovery and recycle of the solvent and the unreacted reactants. The second reactive step is
a hydrogenation step that takes place in a fed-batch reactor and the final step is a carbonylation step
that also takes place in a fed-batch reactor. Pathway 2 consists of 3 reactive steps as well—a Friedel
crafts acylation, an 1,2-aryl migration step and a saponification step—all the reactions are taking place
in a continuous flow reactor and this reaction pathway that has been proposed by Snead et al. [73].
Finally, the third reaction pathway consists of the same three reactive steps, as the second pathway,
although the intermediates and reactants are different Bogdan et al. [74]. Table 11 gives a summary of
the reaction pathways retrieved from the database.
Table 11. Summary of the data retrieved from the database.
Pathway Reaction Steps Database Entries Operation Reference
1
1.1 Friedel Crafts
acylation 67 and 74
Batch (67),
continuous (74)
Elango et al. [71]
Lindley et al. [72]
1.2 Hydrogenation 68–71 and 92 Batch Elango et al. [71]
1.3 Carbonylation 9–13 Batch Elango et al. [71]
2 3.1 Friedel Crafts 45 Continuous Snead et al. [73]
3.2 1–2 aryl migration 46 Continuous Snead et al. [73]
3.3 Saponification 44 Continuous Snead et al. [73]
3 2.1 Friedel-Crafts 73 Continuous Bogdan et al. [74]
2.2 1–2,aryl migration 72 Continuous Bogdan et al. [74]
2.3 Saponification 44 Continuous Bogdan et al. [74]
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The details for reaction pathways 1 and 3 are given in the supplementary material (see Sections A.1
and A.2 for pathways 1 and 3 respectively) while the retrieved data for reaction pathway 2 are given
and analyzed in the text below.
5.1.2. Pathway 2: Ibuprofen Synthesis
The individual reaction details for the reaction pathway proposed by Snead et al. [73] are presented
in Table 12, where the reaction is given in terms of reactants and reaction product for each step and
the overall reaction pathway is illustrated in Figure 5. The stoichiometric amounts of the reactants,
the solvents, the catalyst, acid/base and by-products are also given in Table 12 for the three reaction
steps involved in this pathway.
Table 12. Retrieved reaction information from the database.
Reaction
Information
Reaction Step 1 Reaction Step 2 Reaction Step 3
Friedel Crafts (Flow) Aryl Migration (Flow) Saponification (Flow)
Reaction
Isobutylbenzene +
propionyl chloride→
4-isobutylpropiophenone
+ HCl
C13H18O (4-isobutylpropiophenone)
+ C4H10O3 (trimethyl orthoformate)
→ C14H18O2 (Methyl
2-(4-isobutylphenyl) propanoate) +
C3H8O2 (Dimethoxymethane)
C14H21O2 (Methyl
2-(4-isobutylphenyl)
propanoate) + C2H6OS
(2-mercaptoethanol) +
NaOH→ C13H18O2 Na
(ibuprofen sodium salt) +
CH3OH ( MeOH )
Composition
(Reactant A:
Reactant B,
in moles eq.)
1:1.17 1:8 1:8
Solvent Water DMF/1-propanol MeOH/H2O
Catalyst AlCl3 ICI -
Acid/Base HCl - -
By Products - - -
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The reaction conditions in terms of temperature, pressure, residence time, catalyst amount and
solvent amount are listed in Table 13 for all the reaction steps.
Table 13. Reaction Conditions for the three reactive steps.
Reaction Conditions
Reaction Step 1 Reaction Step 2 Reaction Step 3
Friedel Crafts (Flow) Aryl Migration (Flow) Saponification (Flow)
Temperature 87 ◦C 90 ◦C 90 ◦C
Pressure 17 atm 14 atm 14 atm
Residence time 1.25 min 1min 1 min
Catalyst amount 1.11 eq. AlCl3 3 eq. ICI -
Solvent amount - 0.25 eq. DMF/0.71 eq. n-propanol MeOH/H2O (1:3 v/v)
The retrieved experimental data are given in Table 14 in terms of conversion, selectivity, overall
reaction yield, experimental data and model availability.
Table 14. Available experimental data as retrieved from the database.
Type of Data Reaction Step 1 Reaction Step 2 Reaction Step 3
Friedel Crafts (Flow) Aryl Migration (Flow) Saponification (Flow)
Conversion 99% 90% 89%*(*yield)
Selectivity (main
product; by-product) - - -
Reaction Yield - - -
Experimental Steady state data fordifferent residence times
Steady state data for
different residence times
Steady state data for
different residence times
Model No No No
5.1.3. Reaction Pathways Evaluation through the “Green” Metrics
A simple evaluation based on green metrics [38] has been performed and the results are illustrated
in Figure 6. For this analysis, pathway 1 (BHC pathway) with and without recycling of HF and IBB,
pathway 3 proposed by Bogdan et al. [74], and pathway 2 proposed by Snead et al. [73] have been
considered. The effective mass yield, which is a ratio of the produced product (in mass, kg) over the
total amount of non-benign reactant, has been evaluated first. As shown in Figure 6, step 1 of the BHC
synthesis requires larger amounts of non-benign reactants compared to pathways 2 and 3, whereas
reaction steps 2 and 3 require much less non-benign reactants. Another metric that has been evaluated
is the mass intensity (MI), which shows the total required mass for the reaction per kg of product.
In Figure 6b, it can be seen that the first reaction steps of pathways 2 and 3 require fewer reactants
than the amount required for the BHC pathway without considering the recycling. However, when
recycle is considered, the MI metric has lower values for BHC pathway than the other two pathways
where recycle is not possible. In addition, pathway 2 proposes much fewer reactants than are required
by pathway 3.
The E-factor metric, which shows the generated waste per kg of product, has been evaluated for
all the four cases (shown in (Figure 6c). The first step of the BHC pathway has been found to be the
main contributor in the E-factor metric—even if step 1 produces a small amount of waste during the
reaction, the large value of E-factor is caused by the large stoichiometric amounts of needed solvent
and reactant. When the solvent and the reactant are recycled back into the reactor, the E-factor reduces
dramatically and the small value of the E-factor is now caused by the small amount of waste and
non-recovered solvent and reactant (~1%) [72]. The other two pathways (2 and 3) have relatively high
E-factor values, which means that larger amounts of waste are generated through the synthesis steps.
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The generated waste for pathway 2 has been found to be slightly lower compared to the reaction in
pathway 3. Finally, the atom efficiency has been evaluated for the all pathways and is illustrated in
Figure 6d. It can be seen that the atom efficiency for the BHC pathway is very high and therefore, most
of the reactant atoms remain in the final product whereas the atom efficiencies are much lower for the
two new pathways which means that pathways 2 and 3 might generate more waste than the batch
process. Note that the interpretation and the analysis of each “green” metric should be performed
individually for each reaction pathway as they represent different aspects of the process (for example,
waste generation and total mass used per kg of product). Therefore, an overall conclusion about the
“green extent” of the reaction pathways using weighted individual metrics cannot easily be made.
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Figure 6. “Green” metrics evaluation for the reaction pathways found in the reaction database:
(a) effective mass yield (EM) metric, (b) mass intensity (MI) metric, (c) E-Factor metric and (d) atom
efficiency metric.
6. Conclusions
In this article, a reaction database has been developed to assist pharmaceutical process
development during the early stages of the synthesis route selection and process-product development
by providing enhanced process understanding. A data-rich environment is proposed for this task,
where knowledge can be collected, stored and retrieved. The focus of this database is on the
pharmaceutical processes and multiphase reactions taking place within them. The reactions in this
database have been represented in terms of reaction type, target product to be produced (when
single-step or multistep reactions are considered), reaction product and the effect of the solvent use
in the reacting system. Information that is contained in the database includes: reaction conditions
Processes 2017, 5, 58 22 of 25
(temperature, pressure etc.), reaction components (reagents, catalysts etc.), reaction data (conversion,
selectivity, dynamic data set, and kinetic models), scaling information and finally batch or continuous
processing. For each reaction entry, a description of the process together with literature references
are provided.
Reaction data collection is a crucial and very challenging task together with the development of
an appropriate knowledge representation system. Also, verification of the consistency of the data is
necessary but tests for consistency of data are not yet available, except for some phase equilibrium data.
The application of the database has been highlighted by retrieving data for the synthesis of
ibuprofen and using the retrieved data to evaluate the identified reaction pathways using “green”
metrics. This reaction database can be used to provide important information during the development
of pharmaceutical processes at the early stages of process design. The reaction database covers chemical
and biochemical reactions and the future aim is to extend it in terms of reactions and pathways to cover
a wider range of reaction systems-products. Many multiphase reactions or single-phase reactions
have been improved through the use of solvents available in the database. The solvents are either
organic solvents or ionic solvents and in some cases, the extra phase is created by resin, especially for
biochemical processes.
Supplementary Materials: Reaction data and reaction pathways for ibuprofen synthesis. The following are
available online at www.mdpi.com/2227-9717/5/4/58/s1.
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